AYTU All Time Low | Fast Track Designation form FDA todayAYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.
After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.
I think a reversal is imminent.
My price target is $5.25.
Looking forward to read your opinion about it.
Aytuchart
AYTU Momentum Note that the $1.30 price range is a key loading point to get the momentum required to break past the 1.80 price range , If we break past here the next point of resistance would be the 2.05 . Failing to break these levels we could see a 1.30 barcode or even a 1.20 for the comming weeks.
$AYTU: $2.50 Short Target + Long PotentialFirst off, don't take anything I say seriously or at face value, as always this is on opinion basis. That being said, let us get into the points I want to make. AYTU seems to be at one would say a sudden bullish run, as it looks like the resistance curve is about to burst. The earnings call is on May 07th, and alot of price correlations and fluctuations can change as a result of that earnings call. A $2.50 short target is feasible, and it looks like a medium risk long hold position as well.